• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒 2019 患者嗅觉和味觉障碍的恢复率及其相关因素。

Recovery rate and factors associated with smell and taste disruption in patients with coronavirus disease 2019.

机构信息

Lucus Augusti University Hospital, Lugo, Spain.

Lucus Augusti University Hospital, Lugo, Spain.

出版信息

Am J Otolaryngol. 2021 Sep-Oct;42(5):102648. doi: 10.1016/j.amjoto.2020.102648. Epub 2020 Jul 14.

DOI:10.1016/j.amjoto.2020.102648
PMID:33799139
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7358151/
Abstract

PURPOSE

To determine the occurrence of olfactory and gustatory disruptions in COVID-19 patients, their association with demographic and clinical features and prognosis.

MATERIAL AND METHODS

This observational cohort study involved consecutively diagnosed COVID-19 patients tested between March the 3rd 2020 and March the 24th 2020, in a geographically defined cohort area. All COVID-19 patients were evaluated in a University Hospital. The primary outcome of interest is the prevalence of smell and taste alterations, factors associated and recovery rate. Univariate and multivariate analysis by logistic regression was performed to detect factors associated to these symptoms.

RESULTS

151 patients were included and 99 (65.6%) reported olfactory or gustatory symptoms. Olfactory dysfunction was reported by 75 patients (49.7%). Isolated anosmia was found in 2 patients (1.3%). Gustatory dysfunction was reported by 91 patients (60.3%). Factors associated with higher prevalence of smell dysfunction included age, sex, and comorbidities. The time to smell disruption development was significantly shorter in mild to moderate patients than in severe patients (p = 0.043). In 85.3% of patients with smell disruption, the symptom had been resolved in the first 2 months. 14.7% of patients remained symptomatic after 3 months of follow-up.

CONCLUSIONS

Olfactory and gustatory dysfunction was common in COVID-19 patients. Smell disruption has high recovery rate and was associated with age, sex, and clinical severity. It may be beneficial to investigate the appearance of taste and/or smell disruptions in individual patients, with respect to diagnosis and prognosis.

摘要

目的

确定 COVID-19 患者嗅觉和味觉障碍的发生情况,及其与人口统计学和临床特征及预后的关系。

材料和方法

这是一项观察性队列研究,纳入了 2020 年 3 月 3 日至 3 月 24 日期间在地理上定义的队列区域内连续诊断的 COVID-19 患者。所有 COVID-19 患者均在一所大学医院进行评估。主要观察结果是嗅觉和味觉改变的发生率、相关因素和恢复率。采用逻辑回归进行单变量和多变量分析,以检测与这些症状相关的因素。

结果

共纳入 151 例患者,其中 99 例(65.6%)报告存在嗅觉或味觉障碍。75 例(49.7%)患者报告存在嗅觉功能障碍。2 例(1.3%)患者仅表现为嗅觉丧失。91 例(60.3%)患者报告存在味觉功能障碍。与嗅觉功能障碍发生率较高相关的因素包括年龄、性别和合并症。轻度至中度患者嗅觉障碍的发病时间明显短于重度患者(p=0.043)。在嗅觉障碍患者中,85.3%的患者在最初 2 个月内症状得到缓解。在 3 个月的随访后,仍有 14.7%的患者存在症状。

结论

COVID-19 患者中嗅觉和味觉障碍很常见。嗅觉障碍的恢复率较高,与年龄、性别和临床严重程度相关。对于个体患者而言,出现味觉和/或嗅觉障碍可能对诊断和预后有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/333e/7358151/78bbedc523f2/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/333e/7358151/78bd7625ef01/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/333e/7358151/78bbedc523f2/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/333e/7358151/78bd7625ef01/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/333e/7358151/78bbedc523f2/gr2_lrg.jpg

相似文献

1
Recovery rate and factors associated with smell and taste disruption in patients with coronavirus disease 2019.新冠病毒 2019 患者嗅觉和味觉障碍的恢复率及其相关因素。
Am J Otolaryngol. 2021 Sep-Oct;42(5):102648. doi: 10.1016/j.amjoto.2020.102648. Epub 2020 Jul 14.
2
Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.在 COVID-19 大流行期间存在味觉和嗅觉功能障碍。
BMC Infect Dis. 2021 Jun 26;21(1):612. doi: 10.1186/s12879-021-06294-2.
3
COVID-19 Viral Load in the Severity of and Recovery From Olfactory and Gustatory Dysfunction.COVID-19 病毒载量与嗅觉和味觉功能障碍严重程度及恢复的关系。
Laryngoscope. 2020 Nov;130(11):2680-2685. doi: 10.1002/lary.29056. Epub 2020 Sep 8.
4
Eight-month follow-up of olfactory and gustatory dysfunctions in recovered COVID-19 patients.新冠康复患者嗅觉和味觉障碍的 8 个月随访。
Am J Otolaryngol. 2021 Jul-Aug;42(4):103065. doi: 10.1016/j.amjoto.2021.103065. Epub 2021 Apr 20.
5
Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain.西班牙轻度 COVID-19 患者嗅觉和味觉障碍的主观评估。
Med Clin (Barc). 2021 Jan 22;156(2):61-64. doi: 10.1016/j.medcli.2020.08.004. Epub 2020 Sep 25.
6
Olfactory and Gustatory Dysfunctions as a Clinical Manifestation of Coronavirus Disease 2019 in a Malaysian Tertiary Center.嗅觉和味觉障碍作为马来西亚一所 tertiary center 中 2019 冠状病毒疾病的临床特征。
Ann Otol Rhinol Laryngol. 2021 May;130(5):513-519. doi: 10.1177/0003489420963165. Epub 2020 Oct 7.
7
Prevalence of Taste and Smell Dysfunction in Coronavirus Disease 2019.2019 年冠状病毒病味觉和嗅觉功能障碍的流行情况。
JAMA Otolaryngol Head Neck Surg. 2020 Aug 1;146(8):723-728. doi: 10.1001/jamaoto.2020.1155.
8
COVID-19-Related Quantitative and Qualitative Olfactory and Gustatory Dysfunction: Long-Term Prevalence and Recovery Rate.COVID-19 相关的定量和定性嗅觉及味觉功能障碍:长期患病率和恢复率。
ORL J Otorhinolaryngol Relat Spec. 2023;85(2):67-71. doi: 10.1159/000525861. Epub 2022 Sep 5.
9
Evaluating long-term smell or taste dysfunction in mildly symptomatic COVID-19 patients: a 3-year follow-up study.评估轻度症状COVID-19患者的长期嗅觉或味觉功能障碍:一项3年随访研究。
Eur Arch Otorhinolaryngol. 2023 Dec;280(12):5625-5630. doi: 10.1007/s00405-023-08227-y. Epub 2023 Sep 16.
10
Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19.轻度症状 COVID-19 患者嗅觉或味觉改变的演变。
JAMA Otolaryngol Head Neck Surg. 2020 Aug 1;146(8):729-732. doi: 10.1001/jamaoto.2020.1379.

引用本文的文献

1
Potential of traditional medicines in alleviating COVID-19 symptoms.传统药物在缓解新冠病毒疾病症状方面的潜力。
Front Pharmacol. 2024 Sep 26;15:1452616. doi: 10.3389/fphar.2024.1452616. eCollection 2024.
2
One-year psychophysical evaluation of COVID-19-induced olfactory disorders: a prospective cohort study.一项关于 COVID-19 引起的嗅觉障碍的为期一年的心理物理学评估:一项前瞻性队列研究。
BMC Med. 2023 Dec 8;21(1):490. doi: 10.1186/s12916-023-03205-x.
3
Olfactory dysfunction among patients with COVID-19.新冠患者嗅觉功能障碍。

本文引用的文献

1
Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study.新冠病毒感染患者嗅觉和味觉障碍的流行率和恢复情况:一项前瞻性多中心研究。
Am J Rhinol Allergy. 2020 Sep;34(5):686-693. doi: 10.1177/1945892420930954. Epub 2020 Jun 12.
2
The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis.新冠病毒患者嗅觉和味觉功能障碍的流行情况:系统评价和荟萃分析。
Otolaryngol Head Neck Surg. 2020 Jul;163(1):3-11. doi: 10.1177/0194599820926473. Epub 2020 May 5.
3
Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study.
Saudi Med J. 2023 Nov;44(11):1085-1103. doi: 10.15537/smj.2023.44.11.20230264.
4
Erectile dysfunction after COVID-19 recovery: A follow-up study.新冠病毒康复后出现勃起功能障碍:一项随访研究。
PLoS One. 2022 Oct 20;17(10):e0276429. doi: 10.1371/journal.pone.0276429. eCollection 2022.
5
Persistence of COVID-19 symptoms beyond 3 months and the delayed return to the usual state of health in Saudi Arabia: A cross-sectional study.沙特阿拉伯新冠病毒病(COVID-19)症状持续超过3个月及恢复至正常健康状态延迟的横断面研究
SAGE Open Med. 2022 Oct 8;10:20503121221129918. doi: 10.1177/20503121221129918. eCollection 2022.
6
Recovery from Covid-19 smell loss: Two-years of follow up.新冠康复后嗅觉丧失的随访研究:两年观察。
Am J Otolaryngol. 2022 Sep-Oct;43(5):103607. doi: 10.1016/j.amjoto.2022.103607. Epub 2022 Aug 13.
7
The Prevalence and Implications of Olfactory/Gustatory Dysfunctions among Adult COVID-19 Patients: A Retrospective Cohort Multiethnic Populations Study.成年新冠病毒肺炎患者嗅觉/味觉功能障碍的患病率及其影响:一项回顾性队列多民族人群研究
Trop Med Infect Dis. 2022 Jun 23;7(7):115. doi: 10.3390/tropicalmed7070115.
8
Searching for Factors Influencing the Severity of the Symptoms of Long COVID.探寻影响长新冠症状严重程度的因素。
Int J Environ Res Public Health. 2022 Jun 30;19(13):8013. doi: 10.3390/ijerph19138013.
9
International consensus statement on allergy and rhinology: Olfaction.国际过敏与鼻科学学会共识声明:嗅觉。
Int Forum Allergy Rhinol. 2022 Apr;12(4):327-680. doi: 10.1002/alr.22929.
10
Gustatory Function in Acute COVID-19 - Results From Home-Based Psychophysical Testing.急性 COVID-19 患者的味觉功能——基于家庭的心理物理测试结果。
Laryngoscope. 2022 May;132(5):1082-1087. doi: 10.1002/lary.30080. Epub 2022 Mar 1.
COVID-19 大流行期间新发嗅觉丧失后的早期康复 - 一项观察性队列研究。
J Otolaryngol Head Neck Surg. 2020 May 4;49(1):26. doi: 10.1186/s40463-020-00423-8.
4
Potential pathogenesis of ageusia and anosmia in COVID-19 patients.COVID-19患者味觉和嗅觉丧失的潜在发病机制。
Int Forum Allergy Rhinol. 2020 Sep;10(9):1103-1104. doi: 10.1002/alr.22593. Epub 2020 Jun 15.
5
Self-reported olfactory loss associates with outpatient clinical course in COVID-19.自我报告的嗅觉丧失与 COVID-19 门诊临床过程相关。
Int Forum Allergy Rhinol. 2020 Jul;10(7):821-831. doi: 10.1002/alr.22592. Epub 2020 Jun 7.
6
Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients.新型冠状病毒2感染患者味觉减退/嗅觉减退的原因。
J Med Virol. 2020 Oct;92(10):1793-1794. doi: 10.1002/jmv.25903. Epub 2020 Jun 2.
7
Smell dysfunction: a biomarker for COVID-19.嗅觉功能障碍:COVID-19 的生物标志物。
Int Forum Allergy Rhinol. 2020 Aug;10(8):944-950. doi: 10.1002/alr.22587. Epub 2020 Jun 18.
8
Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms.味觉和嗅觉功能障碍与以流感样症状就诊的 COVID-19 患者的关联。
Int Forum Allergy Rhinol. 2020 Jul;10(7):806-813. doi: 10.1002/alr.22579. Epub 2020 Jun 1.
9
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.中国武汉住院的 2019 年冠状病毒病患者的神经系统表现。
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
10
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19.吸烟者和 COPD 患者小气道上皮中的 ACE-2 表达:对 COVID-19 的影响。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00688-2020. Print 2020 May.